Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
Notice of Failure to Satisfy a Continued Listing Standard
On June 2, 2022, OncoSec Medical Incorporated (the "Company") received notice
(the "Notice") from the Nasdaq Stock Market LLC ("Nasdaq") that the Company is
not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price
of the Company's common stock has been below $1.00 per share for 30 consecutive
business days. The Notice has no immediate effect on the listing of the
Company's common stock, which will continue to trade at this time on the Nasdaq
Capital Market under the symbol "ONCS."
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period
of 180 calendar days, or until November 29, 2022, to regain compliance with the
minimum bid price requirement. To regain compliance, the closing bid price of
the Company's common stock must meet or exceed $1.00 per share for at least ten
consecutive business days during this 180 calendar day period. In the event the
Company does not regain compliance by November 29, 2022, the Company may be
eligible for an additional 180 calendar day grace period if it meets the
continued listing requirement for market value of publicly held shares ($1
million) and all other initial listing standards for the Nasdaq Capital Market,
with the exception of the minimum bid price, and provides written notice to
Nasdaq of its intention to cure the deficiency during the second compliance
period by effecting a reverse stock split, if necessary. If the Company does not
regain compliance within the allotted compliance period(s), Nasdaq will provide
notice that the Company's common stock will be subject to delisting from the
Nasdaq Capital Market. In that event, the Company may appeal such delisting
determination to a hearings panel.
The Company intends to monitor the closing bid price of its common stock and
consider options to resolve its noncompliance with the minimum bid price
requirement.
© Edgar Online, source Glimpses